United States Biotechnology & Medical Research

Agenus Inc (AGEN)

Track

Agenus Inc has recorded no insider trading activity within the past three months. The most recent transactions occurred in February 2024, involving share acquisitions by company leadership. Historical data shows a mix of buying and selling patterns by various stakeholders over several years, with no significant recent market participation by corporate officers.
Ticker: AGEN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Agenus Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 15 Feb 2024
Value US$4,896,087.22 | Price 24.25 | Shares 86,180 (-41.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-15 2024-02-15 B Purchase
2.4
ARMEN GARO H

See Remarks

Executive Director
86,180 -41.7%
24.25
US$4,896,087 		86,180 -41.7% 24.25 US$4,896,087
2023-11-17 2023-11-15 B Purchase
3.4
WIINBERG ULF
Non-Executive Director
66,742 -0.8%
229.71
US$4,589,587 		66,742 -0.8% 229.71 US$4,589,587
2022-01-06 2022-01-06 S Sale
3.2
O'Day Steven J

Chief Medical Officer

Officer
88,536 +42.0%
439.37
US$1,813,479 		88,536 +42.0% 439.37 US$1,813,479
2021-09-14 2021-09-13 S Sale
2.4
ARMEN GARO H

Chairman and CEO

Executive Director
82,107 -9.6%
6.50
US$533,696 		82,107 -9.6% 6.50 US$533,696
2021-09-14 2021-09-10 S Sale
3.3
KLASKIN CHRISTINE M

PFO & PAO

Officer
11,120 -10.7%
6.50
US$72,280 		11,120 -10.7% 6.50 US$72,280
2020-06-18 2020-06-17 S Sale
1.5
INCYTE CORP
Large shareholder
141,920 -0.8%
3.66
US$518,831 		141,920 -0.8% 3.66 US$518,831
2020-06-18 2020-06-16 S Sale
1.5
INCYTE CORP
Large shareholder
72,080 -0.4%
3.66
US$264,007 		72,080 -0.4% 3.66 US$264,007
2020-06-15 2020-06-15 S Sale
1.5
INCYTE CORP
Large shareholder
384,025 -2.2%
3.57
US$1,372,160 		384,025 -2.2% 3.57 US$1,372,160
2020-06-15 2020-06-12 S Sale
1.5
INCYTE CORP
Large shareholder
9,100 -0.1%
3.58
US$32,556 		9,100 -0.1% 3.58 US$32,556
2020-06-15 2020-06-11 S Sale
1.5
INCYTE CORP
Large shareholder
183,875 -1.0%
3.77
US$692,786 		183,875 -1.0% 3.77 US$692,786
2017-12-14 2017-12-12 S Sale Baysal Ozer

Chief Commercial Officer
3,712 -5.9%
3.46
US$12,846 		3,712 -5.9% 3.46 US$12,846
2017-12-14 2017-12-12 S Sale Valentine Karen

Chief Legal Officer
8,358 -7.6%
3.46
US$28,921 		8,358 -7.6% 3.46 US$28,921
2017-12-14 2017-12-12 S Sale Duncan Alex

Chief Technology Officer
6,546 -23.7%
3.46
US$22,651 		6,546 -23.7% 3.46 US$22,651
2017-12-14 2017-12-12 S Sale Buell Jennifer

Chief Communications Officer
3,511 -9.0%
3.46
US$12,152 		3,511 -9.0% 3.46 US$12,152
2017-12-14 2017-12-12 S Sale KLASKIN CHRISTINE M

VP, Finance
5,610 -8.0%
3.46
US$19,418 		5,610 -8.0% 3.46 US$19,418
2017-04-12 2017-04-12 B Purchase ARMEN GARO H

Chairman & CEO

Executive Director
29,456 +2.1%
3.29
US$97,055 		29,456 +2.1% 3.29 US$97,055
2017-04-12 2017-04-10 B Purchase ARMEN GARO H

Chairman & CEO

Executive Director
70,544 +5.4%
3.37
US$237,465 		70,544 +5.4% 3.37 US$237,465
2017-02-14 2017-02-14 B Purchase INCYTE CORP Large shareholder
10,000,000 +128.8%
6.00
US$60,000,000 		10,000,000 +128.8% 6.00 US$60,000,000
2016-09-08 2016-09-06 B Purchase WIINBERG ULF Non-Executive Director
30,000 +inf%
6.29
US$188,700 		30,000 +inf% 6.29 US$188,700
2016-05-10 2016-05-09 B Purchase ARMEN GARO H

Chairman & CEO

Officer
50,000 +3.7%
3.28
US$163,935 		50,000 +3.7% 3.28 US$163,935
2016-05-10 2016-05-05 B Purchase ARMEN GARO H

Chairman & CEO

Officer
50,000 +3.9%
3.08
US$153,960 		50,000 +3.9% 3.08 US$153,960
2016-05-09 2016-05-05 B Purchase Baysal Ozer

Chief Business Officer

Officer
2,250 +7.2%
3.10
US$6,975 		2,250 +7.2% 3.10 US$6,975
2016-03-08 2016-03-07 B Purchase ARMEN GARO H

Chairman & CEO

Officer
200,000 +19.0%
4.03
US$805,600 		200,000 +19.0% 4.03 US$805,600
2015-12-30 2015-12-29 S Sale ARMEN GARO H

Chairman & CEO

Officer
85,224 -6.6%
4.57
US$389,602 		85,224 -6.6% 4.57 US$389,602
2015-12-30 2015-12-28 S Sale ARMEN GARO H

Chairman & CEO

Officer
89,917 -6.5%
4.59
US$413,142 		89,917 -6.5% 4.59 US$413,142
2015-12-30 2015-12-28 S Sale ARMEN GARO H

Chairman & CEO

Officer
44,435 -3.1%
4.62
US$205,134 		44,435 -3.1% 4.62 US$205,134
2015-09-29 2015-09-25 B Purchase ARMEN GARO H

Chairman & CEO

Officer
100,000 +7.6%
5.03
US$503,000 		100,000 +7.6% 5.03 US$503,000
2015-09-29 2015-09-25 B Purchase Ballantyne Charles Evan

Chief Financial Officer

Officer
10,000 +inf%
5.05
US$50,500 		10,000 +inf% 5.05 US$50,500
2015-04-30 2015-04-29 S Sale Malik Shahzad Non-Executive Director
407,377 -100.0%
7.02
US$2,858,809 		407,377 -100.0% 7.02 US$2,858,809
2015-04-30 2015-04-28 S Sale Malik Shahzad Non-Executive Director
700,000 -63.2%
7.16
US$5,012,560 		700,000 -63.2% 7.16 US$5,012,560
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
41,830 -0.6%
5.33
US$222,954 		41,830 -0.6% 5.33 US$222,954
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
83,100 -1.2%
5.31
US$441,261 		83,100 -1.2% 5.31 US$441,261
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
100,000 -1.4%
5.35
US$535,000 		100,000 -1.4% 5.35 US$535,000
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
89,800 -1.2%
5.49
US$493,002 		89,800 -1.2% 5.49 US$493,002
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
50,000 -0.7%
5.44
US$272,000 		50,000 -0.7% 5.44 US$272,000
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
100,000 -1.4%
5.20
US$520,000 		100,000 -1.4% 5.20 US$520,000
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
43,080 -0.6%
5.57
US$239,956 		43,080 -0.6% 5.57 US$239,956
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
856,920 -10.3%
5.18
US$4,438,846 		856,920 -10.3% 5.18 US$4,438,846
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
215,000 -2.5%
5.19
US$1,115,850 		215,000 -2.5% 5.19 US$1,115,850
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
400,000 -4.5%
5.62
US$2,248,000 		400,000 -4.5% 5.62 US$2,248,000
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
53,606 -0.6%
5.21
US$279,287 		53,606 -0.6% 5.21 US$279,287
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
146,394 -1.6%
5.27
US$771,496 		146,394 -1.6% 5.27 US$771,496
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
143,900 -1.6%
5.30
US$762,670 		143,900 -1.6% 5.30 US$762,670
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
20,000 -0.2%
5.55
US$111,000 		20,000 -0.2% 5.55 US$111,000
2011-12-29 2011-12-29 S Sale Wentworth Kerry

VP, Clinical, Reg, & Quality

Officer
8,939 -36.6%
2.01
US$17,967 		8,939 -36.6% 2.01 US$17,967
2011-12-29 2011-12-29 S Sale Valentine Karen

VP, General Counsel

Officer
7,605 -86.5%
1.98
US$15,058 		7,605 -86.5% 1.98 US$15,058
2011-12-29 2011-12-28 S Sale Sharp Shalini

CFO

Officer
1,711 -3.9%
2.09
US$3,576 		1,711 -3.9% 2.09 US$3,576
2011-12-29 2011-12-28 S Sale Wentworth Kerry

VP, Clinical, Reg, & Quality

Officer
1,893 -7.2%
2.09
US$3,956 		1,893 -7.2% 2.09 US$3,956
2011-12-29 2011-12-28 S Sale Valentine Karen

VP, General Counsel

Officer
1,301 -12.9%
2.09
US$2,719 		1,301 -12.9% 2.09 US$2,719
2011-12-29 2011-12-27 S Sale Sharp Shalini

CFO

Officer
2,853 -6.2%
2.14
US$6,105 		2,853 -6.2% 2.14 US$6,105
2011-12-29 2011-12-27 S Sale KLASKIN CHRISTINE M

VP, Finance

Officer
1,824 -12.6%
2.14
US$3,903 		1,824 -12.6% 2.14 US$3,903
2011-12-29 2011-12-27 S Sale Wentworth Kerry

VP, Clinical, Reg, & Quality

Officer
3,156 -10.7%
2.14
US$6,754 		3,156 -10.7% 2.14 US$6,754
2011-12-29 2011-12-27 S Sale Valentine Karen

VP, General Counsel

Officer
2,169 -17.7%
2.14
US$4,642 		2,169 -17.7% 2.14 US$4,642
2011-12-23 2011-12-23 S Sale KLASKIN CHRISTINE M

VP Finance

Officer
511 -3.4%
2.20
US$1,123 		511 -3.4% 2.20 US$1,123
2011-12-23 2011-12-23 S Sale Wentworth Kerry

VP, Clinical, Reg, & Quality

Officer
886 -2.9%
2.20
US$1,947 		886 -2.9% 2.20 US$1,947
2011-12-23 2011-12-23 S Sale Valentine Karen

VP, General Counsel

Officer
608 -4.7%
2.20
US$1,336 		608 -4.7% 2.20 US$1,336
2011-12-23 2011-12-23 S Sale Sharp Shalini

CFO

Officer
795 -1.7%
2.20
US$1,747 		795 -1.7% 2.20 US$1,747
2011-12-23 2011-12-22 S Sale KLASKIN CHRISTINE M

VP Finance

Officer
993 -6.2%
2.19
US$2,175 		993 -6.2% 2.19 US$2,175
2011-12-23 2011-12-22 S Sale Wentworth Kerry

VP, Clinical, Reg, & Quality

Officer
1,716 -5.4%
2.19
US$3,759 		1,716 -5.4% 2.19 US$3,759
2011-12-23 2011-12-22 S Sale Valentine Karen

VP, General Counsel

Officer
1,177 -8.4%
2.19
US$2,578 		1,177 -8.4% 2.19 US$2,578
2011-12-23 2011-12-22 S Sale Sharp Shalini

CFO

Officer
1,548 -3.2%
2.19
US$3,391 		1,548 -3.2% 2.19 US$3,391
2011-12-23 2011-12-21 S Sale KLASKIN CHRISTINE M

VP Finance

Officer
1,975 -11.0%
2.24
US$4,420 		1,975 -11.0% 2.24 US$4,420
2011-12-23 2011-12-21 S Sale Wentworth Kerry

VP, Clinical, Reg, & Quality

Officer
3,414 -9.6%
2.24
US$7,641 		3,414 -9.6% 2.24 US$7,641
2011-12-23 2011-12-21 S Sale Valentine Karen

VP, General Counsel

Officer
2,348 -14.3%
2.24
US$5,255 		2,348 -14.3% 2.24 US$5,255
2011-12-23 2011-12-21 S Sale Sharp Shalini

CFO

Officer
3,087 -6.0%
2.24
US$6,909 		3,087 -6.0% 2.24 US$6,909
2011-10-03 2011-09-30 B Purchase ARMEN GARO H

Chairman & CEO

Officer
16,666 +1.9%
2.99
US$49,768 		16,666 +1.9% 2.99 US$49,768
2011-08-17 2011-08-16 B Purchase ARMEN GARO H

Chairman & CEO

Officer
2,150,976 +67.7%
0.51
US$1,096,998 		2,150,976 +67.7% 0.51 US$1,096,998
2010-05-19 2010-05-18 B Purchase Wright Timothy Non-Executive Director
10,000 +inf%
1.34
US$13,400 		10,000 +inf% 1.34 US$13,400
2010-03-18 2010-03-16 S Sale Valentine Karen

VP and General Counsel

Officer
29,039 -36.1%
0.76
US$22,006 		29,039 -36.1% 0.76 US$22,006
2009-06-29 2009-06-25 B Purchase ARMEN GARO H

Chairman & CEO

Officer
25,000 +2.2%
1.97
US$49,250 		25,000 +2.2% 1.97 US$49,250
2009-02-25 2009-02-25 B Purchase HATSOPOULOS JOHN Non-Executive Director
10,000 +22.2%
0.37
US$3,700 		10,000 +22.2% 0.37 US$3,700
2008-09-05 2008-09-04 B Purchase HATSOPOULOS JOHN Non-Executive Director
3,000 +7.1%
1.72
US$5,160 		3,000 +7.1% 1.72 US$5,160
2008-09-05 2008-09-03 B Purchase HATSOPOULOS JOHN Non-Executive Director
7,000 +20.0%
1.71
US$11,970 		7,000 +20.0% 1.71 US$11,970
2008-05-20 2008-05-16 B Purchase MARGARET EISEN Non-Executive Director
15,000 +300.0%
2.36
US$35,348 		15,000 +300.0% 2.36 US$35,348
2008-01-11 2008-01-09 B Purchase ARMEN GARO H

Chairman and CEO

Officer
1,166,667 +10.2%
3.00
US$3,500,001 		1,166,667 +10.2% 3.00 US$3,500,001
Explore more

More insider trading research around Agenus Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America